Home › Stocks › EBS

Emergent BioSolutions Inc. (EBS): insider buying, hedge funds & Congress trades

Emergent BioSolutions Inc. (EBS): 1 insider purchase in the last two years; 1 trade disclosed by members of Congress.

Insider buying

FiledInsiderSharesPriceValueType
May 15, 2025Papa Joseph C
Director, Officer
60,000$5.83$349.8Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for EBS

Free account. Know when insiders, famous funds or Congress trade it.

Start free

Congress trades in EBS

FiledMemberTypeAmount
Jan 10, 2025Steve Cohensale$1,001 - $15,000